Publications of Tilia Marlene Zinnecker

Zinnecker, T. M.; Badri, N.; Araujo, D.; Thiele, K.; Reichl, U.; Genzel, Y.: From single‐cell cloning to high‐yield influenza virus production – implementing advanced technologies in vaccine process development. Engineering in Life Sciences 24 (4), 2300245 (2024)

Zinnecker, T. M.; Reichl, U.; Genzel, Y.: Innovations in cell culture-based influenza vaccine manufacturing – from static cultures to high cell density cultivations. Human Vaccines & Immunotherapeutics 20 (1), 2373521 (2024)

Zinnecker, T. M.; Behrendt, I.; Lau, M.; Hinkelmann, A.; Thiele, K.; Badri, N.; Araujo, D.; Genzel, Y.; Reichl, U.: Automated single-cell cloning in chemically defined medium for new suspension MDCK cell lines and scale-down of influenza A virus production into ambr^®15 microbioreactors. In Proceedings Vaccine Technology VIII, 55. Vaccine Technology VIII, Sitges (Spain), June 12, 2022 - June 17, 2022. (2022)

Genzel, Y.; Zinnecker, T. M.; Göbel, S.; Reichl, U.: Next-generation virus production: from clone, to AMBR, to perfusion and very high virus yield. 8th Edition of the "International Symposium on Immunobiologicals" (8th ISI), Rio de Janeiro (Brazil) (2024)

Zinnecker, T. M.; Thiele, K.; Schmidberger, T.; Reichl, U.; Genzel, Y.: Influenza A Virus Production following Quality by Design Principles. Vaccine Technology IX, Los Cabos (Mexico) (2024)

Genzel, Y.; Zinnecker, T. M.; Göbel, S.; Reichl, U.: Intensified cell-based virus production: A process development challenge for multiple cell-virus combinations. 16^th PEACe Conference, Sitges (Spain) (2023)

Genzel, Y.; Zinnecker, T. M.; Göbel, S.; Reichl, U.: Next-Generation Virus Production: From Clone, to AMBR, to Perfusion and Very High Virus Yield. International Society for Vaccines (ISV) Annual Congress, Lausanne (Switzerland) (2023)

Genzel, Y.; Zinnecker, T. M.; Göbel, S.; Reichl, U.: Increase in supply through use of new technologies for high yield vaccines. Flanders Vaccine, Brussels (Belgium) (2023)

Zinnecker, T. M.; Badri, N.; Araujo, D.; Hinkelmann, A.; Thiele, K.; Reichl, U.; Genzel, Y.: Novel approach towards vaccine manufacturing: from single-cell cloning to high-yielding influenza virus production. 4^th Global Bioprocessing, Bioanalytics and ATMP Manufacturing Congress, Dublin (Ireland) (2023)

Zinnecker, T. M.; Badri, N.; Araujo, D.; Hinkelmann, A.; Thiele, K.; Reichl, U.; Genzel, Y.: A quest for the best influenza producing clonal MDCK cell line: intensifying by design of experiments, ambr15 and bench-top bioreactor cultivations. World Biopharm Forum 2023 - Democratisation of biotherapies: new manufacturing modalities and intensifications, Oxford (United Kingdom) (2023)

Zinnecker, T. M.; Behrendt, I.; Lau , M.; Hinkelmann, A.; Thiele, K.; Badri, N.; Araujo, D.; Genzel, Y.; Reichl, U.: Automated single-cell cloning in chemically defined medium for new suspension MDCK cell lines and scale-down of influenza A virus production into ambr^®15 microbioreactors. Vaccine Technology VIII, Sitges (Spain) (2022)

Zinnecker, T. M.; Thiele, K.; Schmidberger, T.; Reichl, U.; Genzel, Y.: Influenza A Virus Production following Quality by Design Principles. Vaccine Technology IX, Los Cabos (Mexico) (2024)

Zinnecker, T. M.; Thiele, K.; Schmidberger, T.; Reichl, U.; Genzel, Y.: Implementation of Quality by Design Principles for Influenza A Virus Production. 28th ESACT Meeting, Edingburgh (Scotland) (2024)

Zinnecker, T. M.; Badri, N.; Araujo, D.; Thiele, K.; Genzel, Y.; Reichl, U.: Generation and screening of monoclonal suspension MDCK cells for high-yield influenza A virus production. 3rd ESACT Frontiers Retreat, Vienna, Austria (2022)

Zinnecker, T. M.; Behrendt, I.; Lau , M.; Hinkelmann, A.; Thiele, K.; Badri, N.; Araujo, D.; Genzel, Y.; Reichl, U.: Automated single-cell cloning in chemically defined medium for new suspension MDCK cell lines and scale-down of influenza A virus production into ambr^®15 microbioreactors. Vaccine Technology VIII, Sitges (Spain) (2022)

Zinnecker, T. M.; Behrendt, I.; Lau, M.; Hinkelmann, A.; Thiele, K.; Badri, N.; Araujo, D.; Genzel, Y.; Reichl, U.: Suspension MDCK cell line development by automated single-cell cloning & scale-down into ambr^®15 microbioreactors in chemically defined medium. 27th ESACT Meeting, Lisbon (Portugal) (2022)

Zinnecker, T. M.: Single-Cell Analysis of Influenza A Virus Defective Interfering Particle Infection. Master, Technische Universität, Berlin (2021)